中德携手，共绘单孔超微创手术新蓝图—德国慕尼黑市立医院专家造访，术锐 机器人加速全球化布局

Core Viewpoint - The visit of the German expert team to China marks the official initiation of international clinical cooperation in robotic minimally invasive surgery between the Chinese company, Shurui Robotics, and Germany's top medical institutions [1][4]. Group 1: Expert Visit and Collaboration - The expert team from Munich Clinic Bogenhausen visited China to learn about Shurui's single-port laparoscopic surgical robot and engage in technical exchanges with Ruijin Hospital [1]. - The visit included a tour of Shurui's R&D center in Shanghai, where the experts experienced the unique advantages of the robotic system, including multi-degree-of-freedom control and high load capacity [2]. - The clinical application of the Shurui robot was demonstrated through various surgeries, showcasing its capabilities across multiple disciplines such as general surgery, thoracic surgery, and urology [2]. Group 2: Academic Exchange and Knowledge Sharing - Prior to the surgical observation, an academic exchange was held where Prof. Johannes Bodner discussed the status of minimally invasive surgery and robotic applications in Germany [3]. - The discussions included topics such as robotic surgical techniques, operational strategies, and training systems, laying a solid foundation for future clinical observations [3]. - Ruijin Hospital's Director Liu Kun shared insights on the hospital's development and its achievements in robotic minimally invasive surgery, emphasizing the establishment of a standardized training and evaluation system for domestic robotic surgery [3]. Group 3: Technological Recognition and Future Plans - The German experts recognized the operational freedom, flexibility, and precision of the Shurui robot during the surgical observation [4]. - Shurui Robotics is the second globally approved single-port laparoscopic surgical robot and represents a significant advancement in China's high-end medical equipment [4]. - The collaboration with Munich Clinic Bogenhausen signifies a formal connection between China and Germany in the field of surgical robotics, with plans to conduct clinical trials in Germany to introduce Chinese innovations to the European medical system [4].